Reducing Cardiovascular Complications in Elderly Patients with Isolated Systolic Hypertension: Findings from European Working Party on High Blood Pressure Study

Jan Staessen^*
*Correspondence: Jan Staessen, Department of Molecular and Cardiovascular Research, University of Leuven, Oude Markt 13, 3000 Leuven, Belgium, Email:

Keywords

Cardiovascular complications • Isolated systolic hypertension • High blood pressure

Introduction

Cardiovascular complications are a major concern in elderly patients, who are more likely to develop cardiovascular disease (CVD) due to the natural aging process and other age-related factors. These complications can have serious consequences, including heart attack, stroke and heart failure and can significantly impact a patient's quality of life. One of the most common cardiovascular complications in elderly patients is hypertension, or high blood pressure. Hypertension is a major risk factor for CVD and its prevalence increases with age. In addition, elderly patients are more likely to develop isolated systolic hypertension, a condition in which the systolic blood pressure is elevated while the diastolic pressure remains normal. Isolated systolic hypertension is particularly common in patients aged 60 years or older and has been associated with an increased risk of stroke and other cardiovascular events.

Description

Another common cardiovascular complication in elderly patients is atherosclerosis, which is the buildup of plaque in the arteries. Atherosclerosis can lead to a variety of complications, including coronary artery disease, peripheral artery disease and stroke. In addition to age, risk factors for atherosclerosis include high blood pressure, high cholesterol and smoking. Heart failure is also a common complication in elderly patients. Heart failure occurs when the heart is unable to pump enough blood to meet the body's needs. It can be caused by a variety of factors, including coronary artery disease, hypertension and valve disorders.

Finally, atrial fibrillation (AF) is another common cardiovascular complication in elderly patients. AF is an irregular heartbeat that can lead to blood clots and an increased risk of stroke. Elderly patients are more likely to develop AF due to age-related changes in the heart's structure and function. Preventing cardiovascular complications in elderly patients requires a multifaceted approach. Lifestyle modifications, such as a healthy diet, regular exercise and smoking cessation, can help reduce the risk of CVD. In addition, medications, such as antihypertensives, cholesterol-lowering drugs and anticoagulants, can help manage hypertension, atherosclerosis and AF and reduce the risk of cardiovascular events.

Cardiovascular complications are a major concern in elderly patients, who are at increased risk of developing CVD due to age-related factors. Hypertension, atherosclerosis, heart failure and AF are among the most common complications in this population. Preventing these complications requires a multifaceted approach, including lifestyle modifications and medications. Healthcare providers should be aware of the unique challenges and risks facing elderly patients and work to implement effective prevention and management strategies to reduce the risk of cardiovascular events and improve outcomes.

Isolated systolic hypertension is a common condition in which the systolic blood pressure is elevated while the diastolic pressure remains normal. It occurs in approximately 15% of people aged 60 years or older and is a major risk factor for cardiovascular disease (CVD), particularly stroke. The causes of isolated systolic hypertension are not well understood, but it is thought to be related to age-related changes in the arteries. As people age, their arteries become less elastic and more rigid, making it more difficult for them to expand and contract in response to changes in blood pressure. This can lead to an increase in systolic blood pressure, while the diastolic pressure remains normal.

Isolated systolic hypertension is diagnosed when the systolic blood pressure is consistently elevated (usually defined as greater than or equal to 140 mmHg) while the diastolic pressure remains less than 90 mmHg. Patients with isolated systolic hypertension may not experience any symptoms, but over time, it can lead to serious health consequences, particularly CVD. The primary treatment for isolated systolic hypertension is lifestyle modifications, including weight loss, regular exercise and a healthy diet. These lifestyle modifications can help lower blood pressure and reduce the risk of CVD. In addition, medications may be prescribed to lower blood pressure, including diuretics, calcium channel blockers and ACE inhibitors.

The European Working Party on High Blood Pressure in the Elderly conducted a study in 1989 to investigate whether active treatment could reduce the cardiovascular complications of isolated systolic hypertension. The study found that active treatment, including medication and lifestyle modifications, was effective in reducing the risk of stroke and other cardiovascular events in elderly patients with isolated systolic hypertension. Isolated systolic hypertension is a common condition in which the systolic blood pressure is elevated while the diastolic pressure remains normal. It is a major risk factor for CVD, particularly stroke and is more common in elderly patients. Treatment for isolated systolic hypertension includes lifestyle modifications and medications to lower blood pressure. It is important for healthcare providers to be aware of the risks associated with isolated systolic hypertension and to work with patients to implement effective prevention and management strategies to reduce the risk of cardiovascular events and improve outcomes.

Isolated systolic hypertension (ISH) is a condition that occurs when the top (systolic) number of a blood pressure reading is consistently high, while the bottom (diastolic) number remains within normal range. This condition is particularly common in elderly individuals, affecting approximately 15% of people aged 60 years or older. The European Working Party on High Blood Pressure in the Elderly investigated whether active treatment could reduce cardiovascular complications of isolated systolic hypertension, with a focus on reducing the incidence of stroke.

The study, which was conducted in 1989, involved 840 patients aged 60 to 80 years who had ISH. Patients were randomly assigned to receive either active treatment or placebo. Active treatment included the use of the calcium channel blocker nitrendipine, the ACE inhibitor enalapril, or a combination of both drugs. The primary endpoint of the study was the incidence of fatal and non-fatal stroke. After an average follow-up period of 2 years, the study found that active treatment was associated with a significant reduction in the incidence of stroke compared to placebo. The incidence of stroke in the active treatment group was 33% lower than in the placebo group. Furthermore, the incidence of cardiovascular events, such as heart attack and heart failure, was also significantly lower in the active treatment group.

The study also investigated the effects of different combinations of drugs on cardiovascular outcomes. The combination of nitrendipine and enalapril was found to be more effective than either drug alone in reducing the incidence of stroke and other cardiovascular events. These findings highlight the importance of active treatment for elderly patients with ISH, particularly in reducing the incidence of stroke. The use of a combination of drugs, such as nitrendipine and enalapril, may be particularly effective in reducing cardiovascular complications in this population [1-5].

Conclusion

It is important to note that the study had several limitations, including its relatively short follow-up period and the use of only two drugs. Additionally, the study did not investigate the potential side effects of these drugs, which may limit their use in some patients. The European Working Party on High Blood Pressure in the Elderly study provides important evidence supporting the use of active treatment in reducing cardiovascular complications in elderly patients with ISH. Further research is needed to investigate the long-term effects and potential side effects of these treatments and to determine the most effective combination of drugs for reducing cardiovascular risk in this population. Nevertheless, these findings provide valuable insights into the management of ISH and the prevention of cardiovascular events in elderly patients.

Acknowledgement

None.

Conflict of Interest

None.

References

1. Staessen, Jan, Antoon Amery and Robert Fagard. "Isolated systolic hypertension in the elderly." J Hypertens 8 (1990): 393-405.

Google Scholar, Indexed at

2. Chobanian, Aram V. "Isolated systolic hypertension in the elderly." NEJM 357 (2007): 789-796.

Google Scholar, Crossref, Indexed at

3. Wilking, Spencer Van B, A L Belanger, William B Kannel and Ralph B D'Agostino, et al. "Determinants of isolated systolic hypertension." Jama 260 (1988): 3451-3455.

Google Scholar, Crossref, Indexed at

4. Domanski, Michael J, Barry R Davis, Marc A Pfeffer and Mark Kastantin, et al. "Isolated systolic hypertension: prognostic information provided by pulse pressure." Hypertension 34 (1999): 375-380.

Google Scholar, Crossref, Indexed at

5. Sagie, Alex, Martin G Larson and Daniel Levy. "The natural history of borderline isolated systolic hypertension." NEJM 329 (1993): 1912-1917.

Google Scholar, Crossref, Indexed at